Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Lexagene Holdings Inc. (V:LXG)

Business Focus: Bio Diagnostics & Testing

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for LXG within the last 6 months
See all filings within the past 6 months

Company News

Jan 03, 2022 07:45 ET
LexaGene Starts the Year with Additional MiQLab Sales
LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to announce three additional purchase orders for MiQLab™...
Read full article
Dec 17, 2021 13:08 ET
LexaGene Announces Results of Annual General and Special Meeting
LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to announce the voting results of the Company’s 2021 Annual...
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 202154,661-39,643
Dec 15, 202194,30456,519
Nov 30, 202137,785-5,572
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Lexagene Holdings Inc. is a molecular diagnostics company. The Company is focused on developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The Company's MiQLab is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its on-site, automated rapid pathogen detection technology is used for testing in human clinical diagnostics, veterinary diagnostics, food safety, and more. Its veterinary diagnostics system enables veterinarians to rapidly identify infectious pathogens and antibiotic resistance factors in cats and dogs, providing actionable insights in initial diagnosis and prescribed therapies.

See business summary



Search (past week) for $LXG.CA LXG.V